Specialty drugs are driving payer costs and can be very intimidating to manage. Many of these drugs are used to treat serious disease states, including MS, bleeding disorders and cancer. Come hear Kelly Chillingworth examine how, rather than being centered on saying “no” to access, management should instead focus on appropriate use, removing waste and preventing duplication of related services.